SLC2A4 and Insulin resistance: Metabolic Dysfunction: These findings were the result of decreased expression of both AMKP and GLUT-4 in skeletal muscle, which was confirmed by the in vitro experiments. The authors concluded that doxorubicin treatment caused hyperglycaemia and insulin resistance, mediated by inhibition of AMPK.